Trypanosoma cruzi infection in a non-endemic country: Epidemiological and clinical profile

Clinical Microbiology and Infection

Volumn 20, Issue 7, 2014, Pages 706-712

  Salvador, F ^a   Trevino B ^a   Sulleiro, E ^a   Pou, D ^a   Sanchez Montalva A ^a   Cabezos, J ^a   Soriano, A ^a   Serre, N ^a   Gomez i Prat J ^a   Pahissa, A ^a   Molina, I ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cardiac involvement; Chagas disease; Digestive involvement; Non endemic; Trypanosoma cruzi

Indexed keywords

ADULT; AGED; ARTICLE; BARIUM ENEMA; BOLIVIA; CEREBROVASCULAR ACCIDENT; CHAGAS DISEASE; COMPLETE HEART BLOCK; CONSTIPATION; DYSPHAGIA; DYSPNEA; FAINTNESS; FEMALE; HEART PALPITATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPAIN; THORAX PAIN; VERY ELDERLY; ADOLESCENT; DIGESTIVE SYSTEM DISEASES; HEART DISEASES; ISOLATION AND PURIFICATION; MIDDLE AGED; MIGRANT; PARASITOLOGY; PATHOLOGY; TRYPANOSOMA CRUZI; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHAGAS DISEASE; DIGESTIVE SYSTEM DISEASES; EMIGRANTS AND IMMIGRANTS; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPAIN; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84904905044     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12443     Document Type: Article

References (37)

1. Chagas C. Nova tripanozomiase humana. Estudos sobre a morfolojía e o ciclo evolutivo de Schizotrypanum cruzi n. gen., n. sp., ajente etiolójico de nova entidade mórbida do homen. Mem Inst Oswaldo Cruz 1909; 1: 159-218.
2. World Health Organization. Chagas disease (American trypanosomiasis). Data available on http://www.who.int. Last accessed on 1st May 2013.
3. Coura JR, Viñas PA. Chagas disease: a new worldwide challenge. Nature 2010; 465: S6-S7.
4. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problema becoming a world health problem. Acta Trop 2010; 115: 14-21.
5. Rapport d'activités 2006. (Report of activities 2006). La Plaine Saint-Denis: Établissement français du Sang, 2006; 2007.
6. Real Decreto 1088/2005, de 16 de septiembre, por el que se establecen los requisitos técnicos y condiciones mínimas de hemodonación y de los centros y servicios de transfusión. (Royal Decree 1088/2005 of 16 September establishing the minimum technical requisites and conditions for blood donation and for blood transfusion centres and services). Boletín Oficial del Estado. 2005; 225: 31288-304. Madrid: Ministerio de Sanidad y Consumo; 2005. Available from: http://www.boe.es/boe/dias/2005/09/20/pdfs/A31288-31304.pdf.
7. Otero S, Sulleiro E, Molina I et al. Congenital transmission of Trypanosoma cruzi in non-endemic areas: evaluation of a screening program in a tertiary care hospital in Barcelona. Spain. Am J Trop Med Hyg 2012; 87: 832-836.
8. Rassi A Jr, Rassi A, Marín-Neto JA. Chagas disease. Lancet 2010; 375: 1388-1402.
9. Laranja FS, Dias E, Nobrega G, Miranda A. Chagas' disease: a clinical, epidemiological and pathologic study. Circulation 1956; 14: 1035-1060.
10. Coura JR, Anunziato N, Willcox HP. Chagas disease morbidity. I- Study of cases originating in various satates of Brazil, observed in Rio de Janeiro. Mem Inst Oswaldo Cruz 1983; 78: 363-372.
11. Coura JR, de Abreu LL, Dubois LE et al. Morbidity of Chagas' disease. II- Sectional studies in 4 field areas in Brazil. Mem Inst Oswaldo Cruz 1984; 79: 101-124.
12. Brenière SF, Carrasco R, Revollo S, Aparicio G, Desieux P, Tibayrenc M. Chagas' disease in Bolivia: clinical and epidemiological features and zymodeme variability of Trypanosoma cruzi strains isolated from patients. Am J Trop Med Hyg 1989; 41: 521-529.
13. Pless M, Juranek D, Kozarsky P, Steurer F, Tapia G, Bermudez H. The epidemiology of Chagas' disease in a hyperendemic area of Cochabamba, Bolivia: a clinical study including electrocardiography, seroreactivity to Trypanosoma cruzi, xenodiagnosis, and domiciliary triatomine distribution. Am J Trop Med Hyg 1992; 47: 539-546.
14. Borges-Pereira J, Zauza PL, Galhardo MC, Nogueira JD, Pereira GR, Cunha RV. Chagas disease in a urban population of the health district of Rio Verde, Mato Grosso do Sul State, Brazil. Rev Soc Bras Med Trop 2001; 34: 459-466.
15. Borges-Pereira J, Castro JA, Campos JH et al. Study of the infection and morbidity of Chagas disease in municipality of João Costa: National Park Serra da Capirivara, Piauí, Brazil. Rev Soc Bras Med Trop 2002; 35: 315-322.
16. Sánchez-Guillén MC, López-Colombo A, Ordóñez-Toquero G et al. Clinical Forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla. Mexico. Mem Inst Oswaldo Cruz. 2006; 101: 733-740.
17. Moretti E, Castro I, Franceschi C, Basso B. Chagas disease: serological and electrocardiographic studies in Wichi and Creole communities of Misión Nueva Pompeya, Chaco, Argentina. Mem Inst Oswaldo Cruz 2010; 105: 621-627.
18. Muñoz J, Gómez I, Prat J et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop 2009; 111: 51-55.
19. Lescure FX, Paris L, Elghouzzi MH et al. Experience of targeted screening of Chagas disease in Ile-de France. Bull Soc Pathol Exot 2009; 102: 295-299.
20. Pérez-Ayala A, Pérez-Molina J, Norman F et al. Chagas disease in Latin American migrants: a Spanish challenge. Clin Microbiol Infect 2011; 17: 1108-1113.
21. Valerio-Sallent L, Roure S, Basile L, Ballesteros LA, Sabrià M, Rodrigo C; Grupo Metropolitano de studio del Chagas. A clinical and epidemiological study of the Trypanosoma cruzi infected population in the north metropolitan area of Barcelona. Rev Clin Esp 2012; 212: 329-336.
22. Jackson Y, Chappuis F. Chagas disease in Switzerland: history and challenges. Euro Surveill 2011; 16: 19963.
23. Ramos JM, Torrús D, Amador C et al. Multicenter epidemiological and clinical study on imported Chagas disease in Alicante, Spain. Pathog Glob Health 2012; 106: 340-345.
24. Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 2011; 24: 655-681.
25. World Health Organization (WHO). Control of Chagas disease. World Health Organ Tech Rep Ser 2002; 905: 1-109.
26. Riera C, Vergés M, Iniesta L et al. Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg 2012; 86: 412-416.
27. Kuschnir E, Sgammini H, Castro R, Evequoz C, Ledesma R, Brunetto J. Evaluation of cardiac function by radioisotopic angiography in patients with chronic Chagas cardiopathy. Arq Bras Cardio 1985; 45: 249-256.
28. Pérez-Ayala A, Pérez-Molina JA, Norman F, Monge-Maillo B, Faro MV, López-Vélez R. Gastro-intestinal Chagas disease in migrants to Spain: prevalence and methods for early diagnosis. Ann Trop Med Parasitol 2011; 105: 25-29.
29. De Rezende J, Lauar KM, de Oliveira A. Clinical and radiological aspects of aperistalsis of the esophagus. Rev Bras Gastroenterol 1960; 12: 247-262.
30. Ximenes CA. Tecnica simplificada para o diagnóstico radiológico do megacolo chagásico. Rev Soc Bras Med Trop 1984; 17: 23.
31. Velarde-Rodríguez M, Avaria-Saavedra A, Gómez i Prat J et al. Need of comprehensive health care for T. cruzi infected immigrants in Europe. Rev Soc Bras Med Trop 2009; 42: 92-95.
32. Castro C, Bernal-Hernández E, Rezende J, Prata A. Occurrence of dolichocolon without megacolon in chronic Chagas disease patients. Rev Soc Bras Med Trop 2012; 45: 353-356.
33. Bern C. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis 2012; 25: 450-457.
34. Viotti R, Vigliano C, Lococo B et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006; 144: 724-734.
35. Coura JR, de Abreu LL, Willcox HP, Petana W. Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation. Rev Soc Bras Med Trop 1997; 30: 139-144.
36. Pinazo MJ, Muñoz J, Posada E et al. Tolerance of benznidazole in treatment of Chagas' disease in adults. Antimicrob Agents Chemother 2010; 54: 4896-4899.
37. Carrilero B, Murcia L, Martínez-Lage L, Segovia M. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. Rev Esp Quimioter 2011; 24: 123-126.